CD22 and acute lymphoblastic leukemia: In contrast, we found negative correlations between our predicted marker NDST3 and B‐cell surface markers CD22, CD79a, CD19, and CD24 in both datasets, again aligning with the downregulated pattern of NDST3 in B‐ALL compared to T‐ALL (Table 3).